Zhejiang Ausun Pharmaceutical Co Ltd (603229)

Shanghai
Currency in CNY
9.29
+0.03(+0.32%)
Delayed Data·
603229 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
603229 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.219.38
52 wk Range
6.5211.48
Key Statistics
Edit
Bid/Ask
9.29 / 9.30
Prev. Close
9.26
Open
9.3
Day's Range
9.21-9.38
52 wk Range
6.52-11.48
Volume
7.31M
Average Volume (3m)
11.02M
1-Year Change
27.31%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
603229 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Zhejiang Ausun Pharma Company Profile

Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.

Employees
1219
Market
China

Compare 603229 to Peers and Sector

Metrics to compare
603229
Peers
Sector
Relationship
P/E Ratio
36.0x28.0x−0.5x
PEG Ratio
−1.50−0.950.00
Price/Book
3.2x2.9x2.6x
Price / LTM Sales
9.6x4.1x3.2x
Upside (Analyst Target)
7.8%16.2%45.9%
Fair Value Upside
Unlock10.8%7.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.25%
Dividend Yield
1.39%
Industry Median 1.57%
Annualised payout
0.13
Paid annually
5-Years Growth
+43.74%
Growth Streak

Earnings

Latest Release
May 05, 2025
EPS / Forecast
0.14 / --
Revenue / Forecast
306.64M / --
EPS Revisions
Last 90 days

603229 Income Statement

FAQ

What Is the Zhejiang Ausun Pharma (603229) Stock Price Today?

The Zhejiang Ausun Pharma stock price today is 9.29.

What Stock Exchange Does Zhejiang Ausun Pharma Trade On?

Zhejiang Ausun Pharma is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Zhejiang Ausun Pharma?

The stock symbol for Zhejiang Ausun Pharma is "603229."

Does Zhejiang Ausun Pharma Pay Dividends? What’s The Current Dividend Yield?

The Zhejiang Ausun Pharma dividend yield is 1.08%.

What Is the Zhejiang Ausun Pharma Market Cap?

As of today, Zhejiang Ausun Pharma market cap is 7.69B.

What Is Zhejiang Ausun Pharma's Earnings Per Share (TTM)?

The Zhejiang Ausun Pharma EPS (TTM) is 0.25.

When Is the Next Zhejiang Ausun Pharma Earnings Date?

Zhejiang Ausun Pharma will release its next earnings report on 28 Aug 2025.

From a Technical Analysis Perspective, Is 603229 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Zhejiang Ausun Pharma Stock Split?

Zhejiang Ausun Pharma has split 5 times.

How Many Employees Does Zhejiang Ausun Pharma Have?

Zhejiang Ausun Pharma has 1219 employees.

What is the current trading status of Zhejiang Ausun Pharma (603229)?

As of 14 Jul 2025, Zhejiang Ausun Pharma (603229) is trading at a price of 9.29, with a previous close of 9.26. The stock has fluctuated within a day range of 9.21 to 9.38, while its 52-week range spans from 6.52 to 11.48.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.